GLP-1 Newspaper
GLP-1 Newspaper: Daily Ozempic, Zepbound & Weight-Loss Drug News
Follow GLP-1 Newspaper: Daily Ozempic, Zepbound & Weight-Loss Drug News across the charts and keep up with new listener reviews. Get the updates in your inbox.
Track this podcast · 7 days freeCard required. Cancel anytime. Choose your plan at signup.
One GLP-1 story a day, sourced and explained. GLP-1 Newspaper covers the biggest daily news on weight-loss and diabetes drugs like Ozempic, Wegovy, Zepbound, Mounjaro, and new ones like retatrutide, orforglipron, and the Wegovy pill. Each short episode breaks down one story, such as an FDA decision, new trial results, price and insurance changes, shortages, or safety updates. We cover what happened, what it means for patients, and what we don't know yet. Every episode links to its primary sources, like FDA notices, clinical trial records, journals, and company announcements, at glp1newspaper.com. For information only, not medical advice. Always talk to your doctor before starting, stopping, or changing any medication.
© 2026 GLP-1 Newspaper. All rights reserved.
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.